Exercise therapy and lower extremity revascularization both improve walking performance in symptomatic patients with peripheral artery disease, concluded researchers after a comprehensive review of several randomized controlled trials.
A combination exercise therapy and revascularization may result in improved clinical outcomes vs either strategy alone in lower extremity PAD.
Microvascular disease was found to be associated with lower limb amputation, a risk increased in a synergistic manner in individuals with comorbid PAD.
The use of paclitaxel-coated vs uncoated endovascular devices for the treatment of peripheral artery disease was not associated with increased mortality.
Findings based on large, national study of more than 45,000 hemodialysis patients.
Expert consensus decision pathway for anticoagulant and antiplatelet use in patients with atherosclerotic cardiovascular disease or in those with atrial fibrillation or venous thromboembolism undergoing percutaneous coronary intervention.
Increasing severity of white matter lesions are predictive of poor functional outcomes following acute ischemic stroke, but do not alter the effect of EVT.
Statin therapy initiation after index revascularization in patients with peripheral arterial occlusive disease was associated with significant reductions in mortality and cardiovascular events.
The addition of evolocumab to a statin regimen was found to lower the risk for complex coronary disease requiring revascularization in patients with stable atherosclerosis.
The application is supported by data from the double-blind, placebo-controlled phase 3 VOYAGER PAD trial.
